-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Edwards Lifesciences, Raises Price Target to $112

Benzinga·11/05/2026 19:50:49
Listen to the news
Leerink Partners analyst Mike Kratky maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $101 to $112.